Jefferies Group LLC Ironwood Pharmaceuticals Inc Call Options Transaction History

Jefferies Group LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $673,735 - $817,880	-63,500 Closed	0 $0
Q3 2021 Sep 21, 2023	BUY	$11.92 - $13.92 $460,112 - $537,312	38,600 Added 155.02%	63,500 $829,000
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $460,112 - $537,312	38,600 Added 155.02%	63,500 $829,000
Q2 2021 Aug 20, 2021	SELL	$10.16 - $13.11 $25 Million - $32.3 Million	-2,465,100 Reduced 99.0%	24,900 $320,000
Q2 2021 Aug 16, 2021	BUY	$10.16 - $13.11 $25 Million - $32.3 Million	2,465,100 Added 9900.0%	2,490,000 $320,000
Q1 2021 Sep 21, 2023	BUY	$9.04 - $11.86 $225,095 - $295,314	24,900 New	24,900 $278,000
Q1 2021 May 14, 2021	BUY	$9.04 - $11.86 $44,295 - $58,114	4,900 Added 24.5%	24,900 $278,000
Q4 2018 Feb 14, 2019	BUY	$7.8 - $16.13 $156,000 - $322,600	20,000 New	20,000 $207,000

237

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $679M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.